TES of Artemether-lumefantrine for Pf in the Philippines in 2015

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

January 5, 2015

Primary Completion Date

December 30, 2015

Study Completion Date

December 30, 2015

Conditions
Malaria,FalciparumMalaria Recrudescence
Interventions
DRUG

Artemether-lumefantrine

"Artemether-lumefantrine will be administered for 3 days according to body weight (Days 0 and 8 hours after, 1 and 2). Dosage depending on body weight or age if weight cannot be determined.~Dosage: 1 tablet contains 20 mg artemether and 120 mg lumefantrine Dosage per weight: 1 tablet (5 to \<16kg); 2 tablets (15 to \<25kg); 3 tablets (25 to \<35kg), 4 tablets for \>35 kg) Dosage per age, if weight cannot be determined: 1 tablet (6 months old to 3 years old); 2 tablets (4 to 8 years old); 3 tablets (9-13 years old), 4 tablets (\>13 years old)"

DRUG

Primaquine

For Pf patients, primaquine at 0.75 mg base/kg body weight single dose will be given on Day 3 for Pf patients; For Pv patients primaquine will be withheld for 28 days and will be given after Day 28 follow-up, at 0.25 mg base/kg per day for 14 days.

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Research Institute for Tropical Medicine, Philippines

OTHER_GOV

NCT05958693 - TES of Artemether-lumefantrine for Pf in the Philippines in 2015 | Biotech Hunter | Biotech Hunter